Gout flare in the hand of an elderly person Researchers evaluated the efficacy and safety of anakinra for the treatment of acute gout flares. Undergoing 5 days of therapy with the IL-1 receptor ...
The MarketWatch News Department was not involved in the creation of this content. -- Results of a Phase 2a dose escalating study of lingdolinurad (ABP-671) for chronic gout, which enrolled patients ...
Morning Overview on MSN
CRISPR revives ancient gene to block gout and fatty liver
Reviving an ancient human gene that prevents gout and fatty liver disease, scientists at Georgia State University have marked ...
A low dose of colchicine — a commonly used gout drug — helped reduce the risk of heart attack and stroke in people with ...
Treating the acute flare: Acute gout is very painful. Patients with the condition cannot bear weight on an affected joint. Pain management must be the clinician’s first focus. A number of therapies ...
Once gout has been diagnosed, the cause of the hyperuricemia should be identified. The two most common causes of hyperuricemia are decreased renal elimination of urate and excessive alcohol intake. A ...
A newly identified genetic marker may significantly improve the ability to predict life-threatening reactions to the gout medication allopurinol in U.S. patients. While the gene HLA-B*58:01 has long ...
Results of a Phase 2a dose escalating study of lingdolinurad (ABP-671) for chronic gout, which enrolled patients with mild to moderate renal impairment, showed the URAT1 inhibitor lowered serum uric ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results